Owner Scorecard


← The Manual

Volume one · United States

Z

19 entries, Z to ZYME · entries 2,864–2,882 of 3,828

Z Zillow Group Inc. Class C Capital Stock

We are a diversified, transaction-focused platform that integrates our services across various complicated steps in a consumer's housing journey while equipping real estate professionals with tools and insights to support stronger client service and business growth.

Owner earnings 2016–2025 ($53M)$191M($62M)($679M)$338M($3.3B)$4.4B$219M$285M$235M

Retained capital Paid out $4.4B more than it earned over 2016–2025; annual owner earnings grew $221M.

Balance sheet Net debt against an operating loss, $260M · buybacks at an average near $61.08

ZBH Zimmer Biomet Holdings Inc.

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health.

Owner earnings 2016–2025 $1.4B$1.4B$1.6B$1.4B$1.1B$1.4B$1.2B$1.3B$1.3B$1.5B

Retained capital Retained $1.4B of earnings over 2016–2025; annual owner earnings fell $133M, $-0.09 per $1 retained.

Balance sheet Heavy net debt, $6.9B · buybacks at an average near $98.93 · dividend paid 10 of 10 yrs, never cut

ZBIO Zenas BioPharma Inc.

We are a clinical stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need.

Owner earnings 2023–2025 ($31M)($120M)($172M)

Retained capital not read

Balance sheet Net cash, +$265M

ZBRA Zebra Technologies

We are a global leader in the Automatic Identification and Data Capture industry.

Owner earnings 2016–2025 $303M$428M$721M$624M$895M$1.0B$413M($91M)$954M$831M

Retained capital Retained $2.2B of earnings over 2016–2025; annual owner earnings grew $81M, $0.04 per $1 retained.

Balance sheet Meaningful net debt, $2.4B

ZD Ziff Davis

Ziff Davis, Inc. is a vertically focused digital media and internet company whose portfolio includes leading brands in technology, shopping, gaming and entertainment, health and wellness, connectivity, cybersecurity, and martech.

Owner earnings 2016–2025 $258M$225M$345M$342M$388M$403M$230M$211M$284M$288M

Retained capital Retained $203M of earnings over 2016–2025; annual owner earnings fell $15M, $-0.07 per $1 retained.

Balance sheet Heavy net debt, $841M · buybacks at an average near $15.80 · dividend paid 4 of 10 yrs, cut at least once

ZETA Zeta Global Holdings Corp.

Zeta is a leading AI-powered omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software.

Owner earnings 2019–2025 $27M$33M$35M$56M$70M$108M$185M

Retained capital Paid out $909M more than it earned over 2019–2025; annual owner earnings grew $89M.

Balance sheet Net cash, +$123M

ZG Zillow Group Inc.

We are a diversified, transaction-focused platform that integrates our services across various complicated steps in a consumer's housing journey while equipping real estate professionals with tools and insights to support stronger client service and business growth.

Owner earnings 2016–2025 ($53M)$191M($62M)($679M)$338M($3.3B)$4.4B$219M$285M$235M

Retained capital Paid out $4.4B more than it earned over 2016–2025; annual owner earnings grew $221M.

Balance sheet Net debt against an operating loss, $260M · buybacks at an average near $61.08

ZION Zions Bancorporation N.A.

We provide a wide range of banking products and related services, primarily in 11 Western states: Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming.

Owner earnings not applied to a balance-sheet business

Retained capital not applied to a balance-sheet business

Balance sheet a balance-sheet business; the net-cash read is not applied · buybacks at an average near $50.14 · dividend paid 10 of 10 yrs, never cut

ZIONP Zions Bancorporation N.A.

We provide a wide range of banking products and related services, primarily in 11 Western states: Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming.

Owner earnings not applied to a balance-sheet business

Retained capital not applied to a balance-sheet business

Balance sheet a balance-sheet business; the net-cash read is not applied · buybacks at an average near $50.14 · dividend paid 10 of 10 yrs, never cut

ZIP ZipRecruiter Inc.

A software business, earning high margins on code once it is written.

Owner earnings 2019–2025 ($5M)$87M$138M$126M$102M$45M$10M

Retained capital Paid out $503M more than it earned over 2019–2025; annual owner earnings fell $21M.

Balance sheet Net debt against an operating loss, $357M

ZLAB Zai Lab Limited

We are a patient-focused, innovative, commercial-stage, global biopharmaceutical company with a substantial presence in both Greater China and the United States.

Owner earnings 2018–2025 ($99M)($195M)($221M)($556M)($376M)($205M)($221M)($159M)

Retained capital not read

Balance sheet Net cash, debt-free, +$690M

ZM Zoom

Zoom is a platform designed for flexible communication and today's flexible work needs.

Owner earnings 2018–2026 $17M$44M$135M$1.4B$1.6B$1.2B$1.5B$1.8B$1.9B

Retained capital Retained $2.0B of earnings over 2018–2026; annual owner earnings grew $1.7B, $0.83 per $1 retained.

Balance sheet Net cash, debt-free, +$1.3B

ZS Zscaler Inc.

Zscaler Zero Trust Exchange is a cloud-native platform, which implements Zero Trust principles to securely connect users, devices, applications and workloads, including AI agents, without relying on traditional hub-and-spoke network architecture and firewall-centric security.

Owner earnings 2016–2025 ($17M)($14M)$4M$33M$36M$154M$253M$365M$635M$808M

Retained capital Paid out $1.2B more than it earned over 2016–2025; annual owner earnings grew $612M.

Balance sheet Net cash, +$688M

ZSQR Z Squared Inc.

An asset-light business: the value sits in intellectual property and people, not plant, so the question is how durable the advantage is, not how high the margin.

Owner earnings not read

Retained capital not read

Balance sheet Net cash, +$6M

ZTS Zoetis Inc.

Zoetis Inc. is a global leader in the animal health industry, focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health.

Owner earnings 2016–2025 $497M$1.1B$1.5B$1.3B$1.7B$1.7B$1.4B$1.9B$2.5B$2.4B

Retained capital Retained $7.0B of earnings over 2016–2025; annual owner earnings grew $1.2B, $0.17 per $1 retained.

Balance sheet Modest net debt, $6.7B

ZUMZ Zumiez

Zumiez Inc. is a leading specialty retailer of apparel, footwear, accessories and hardgoods for young men and women who want to express their individuality through the fashion, music, art and culture of action sports, streetwear and other unique lifestyles.

Owner earnings 2017–2026 $28M$41M$44M$87M$129M$119M($26M)($6M)$6M$42M

Retained capital Paid out $50M more than it earned over 2017–2026; annual owner earnings fell $24M.

Balance sheet Net cash, +$428M · buybacks at an average near $31.04

ZVRA Zevra Therapeutics Inc.

Revenue is MIPLYFFA (82%) and OLPRUVA (1%).

Owner earnings 2018–2025 ($54M)($24M)($2M)$10M($19M)($34M)($70M)($2M)

Retained capital not read

Balance sheet Net cash, +$478K

ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corporation is a growth-oriented, pure-play water management business that designs, procures, manufactures, and markets what we believe to be the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment.

Owner earnings 2016–2020 $167M$144M$191M$216M$279M

Retained capital Retained $180M of earnings over 2016–2020; annual owner earnings grew $61M, $0.34 per $1 retained.

Balance sheet Modest net debt, $196M · buybacks at an average near $34.93 · dividend paid 1 of 5 yrs, never cut

ZYME Zymeworks Inc.

Zymeworks is a global biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat conditions, including cancer, inflammation, and autoimmune disease.

Owner earnings 2020–2025 ($156M)($205M)$136M($121M)($112M)($35M)

Retained capital not read

Balance sheet Net cash, debt-free, +$258M

The same four lines for every company, in strict ticker order; a figure that could not be read renders as "not read," never as a mark against the record beside it. The entries carry no ranking and form no score. What an entry cannot carry — understanding of the business, and a price — is yours.